Metabolomic Profiling of Middle Ear Effusion Suggests a Predominant Influence of Age over Viscosity: An HR-MAS NMR Study
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms27010020 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Seokhwan Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea. Hauptthemen laut MEDLINE: Otitis Media with Effusion, Metabolomics, Metabolome. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korean government.
Abstract (Originalsprache)
Otitis media with effusion (OME) involves heterogeneous middle ear effusion (MEE), and its classification based on viscosity (serous/mucous) is often confounded by patient age. This study determined the independent contributions of age and viscosity to the MEE metabolome. In this prospective study, high-resolution magic-angle spinning nuclear magnetic resonance analysis of 83 MEE samples (45 adult serous, 17 child serous < 12 years, and 21 child mucous) was performed. Statistical analyses included principal component analysis, correlation analysis, analysis of covariance (ANCOVA), and age-adjusted receiver operating characteristic curve analysis. Age was the primary metabolic variance determinant, overshadowing viscosity-related differences. Significant age-associated metabolic trends were identified: pyruvate and lactate levels increased with age, whereas glutamate and leucine levels decreased, indicating energy and inflammatory metabolism shifts. After adjusting for age using ANCOVA, taurine, glycine, and choline were significantly associated with effusion viscosity, and a combined panel of these metabolites achieved an age-adjusted area under the curve of 0.707 (95% confidence interval: 0.55–0.89). In conclusion, the MEE metabolic profile was more strongly influenced by patient age than by viscosity, suggesting fundamental differences in OME pathophysiology between children and adults. Nonetheless, specific viscosity-associated metabolites were identified, offering a basis for objective metabolic typing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea.
- Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan 43241, Republic of Korea.
- Department of Otorhinolaryngology-Head and Neck Surgery, Pusan National University School of Medicine, Busan 49241, Republic of Korea.
- Department of Otorhinolaryngology, Biomedical Research Institute, Pusan National University Yangsan Hospital, Yangsan 50612, Republic of Korea.
ORCID-Profile: Seokhwan Lee, Seonghye Kim, Sojeon Moon, Hyun-Min Lee, Sung-Won Choi
Förderung
- National Research Foundation of Korea
- Korean government
Zitieren
APA
Lee, S., Kim, S., Moon, S., Oh, S. J., Kim, S. H., Lee, H. M., Kim, S., & Choi, S. W. (2025). Metabolomic Profiling of Middle Ear Effusion Suggests a Predominant Influence of Age over Viscosity: An HR-MAS NMR Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010020
Vancouver
Lee S, Kim S, Moon S, Oh SJ, Kim SH, Lee HM, et al. Metabolomic Profiling of Middle Ear Effusion Suggests a Predominant Influence of Age over Viscosity: An HR-MAS NMR Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010020
BibTeX
@article{Lee2025,
author = {Lee, Seokhwan and Kim, Seonghye and Moon, Sojeon and Oh, Se-Joon and Kim, Seok-Hyun and Lee, Hyun-Min and Kim, Suhkmann and Choi, Sung-Won},
title = {Metabolomic Profiling of Middle Ear Effusion Suggests a Predominant Influence of Age over Viscosity: An HR-MAS NMR Study},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms27010020}
}
EUVIMED